Molecular Cancer Research
短名 | Mol. Cancer. Res. |
Journal Impact | 4.27 |
国际分区 | ONCOLOGY(Q2) |
期刊索引 | SCI Q2中科院 2 区 |
ISSN | 1541-7786, 1557-3125 |
h-index | 153 |
国内分区 | 医学(2区)医学细胞生物学(3区)医学肿瘤学(3区) |
MOLECULAR CANCER RESEARCH 发表文章,描述该领域广泛关注的新型基础癌症研究发现。研究必须具有显着性,并且该杂志优先考虑在分子和细胞水平上进行的分析,这些分析揭示了对与癌症风险、发展和/或进展相关的途径和过程的新机制洞察。重点领域包括所有与癌症相关的途径(包括细胞周期调控;细胞死亡;染色质调控;DNA 损伤和修复;基因和 RNA 调控;基因组学;癌基因和肿瘤抑制因子;信号转导;和肿瘤微环境),此外描述支持癌症表型的新分子机制和相互作用的研究。为了充分考虑,主要研究提交必须提供对现有通路功能的重要新见解,或解决与癌症相关生物学问题相关的新假设。
期刊主页投稿网址涉及主题 | 生物遗传学医学化学生物化学癌症研究内科学基因癌症细胞生物学细胞凋亡信号转导细胞培养细胞免疫学病理磷酸化癌细胞受体 |
出版信息 | 出版商: American Association for Cancer Research Inc.,出版周期: Monthly,期刊类型: journal |
基本数据 | 创刊年份: 2002,原创研究文献占比: 92.81%,自引率:2.40%, Gold OA占比: 21.20% |
平均审稿周期 | 网友分享经验:偏慢,4-8周 |
平均录用比例 | 网友分享经验:较易 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
c-Myc, AKT, Hsc70, and the T-Box Transcription Factor TBX3 Form an Important Oncogenic Signaling Axis in Breast Cancer
2024-9-12
Selected Articles from This Issue
2024-9-4
B-type plexins regulate mitosis via RanGTPase
2024-8-13
EHMT1/2 inhibition promotes regression of therapy-resistant ovarian cancer tumors in a CD8 T cell-dependent manner
2024-8-13
The complex regulation of cytokinesis upon abscission checkpoint activation
2024-8-9
TEAD2 Promotes Hepatocellular Carcinoma Development and Sorafenib Resistance via TAK1 Transcriptional Activation
2024-8-6
Selected Articles from This Issue
2024-8-2
Editor’s Note: Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous Leukemia
2024-8-2
NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion
2024-7-31
Ruthenium drug BOLD-100 regulates BRAFMT colorectal cancer cell apoptosis through AhR/ROS/ATR signaling axis modulation
2024-7-31
GRAIL1 stabilizes misfolded mutant p53 through a ubiquitin ligase-independent, chaperone regulatory function
2024-7-17
Lactate induces tumor progression via LAR motif-dependent Yin-Yang 1 degradation
2024-7-9
HnRNPAB promotes pancreatic ductal adenocarcinoma extravasation and liver metastasis by stablizing MYC mRNA
2024-7-5
NAP1L1 Promotes Endometrial Cancer Progression via EP300-Mediated DDX5 Promoter Acetylation
2024-7-2
Selected Articles from This Issue
2024-7-2
USP44 overexpression drives a MYC-like gene expression program in neuroblastoma through epigenetic reprogramming
2024-7-2
METTL14-mediated Bim mRNA m6A modification augments osimertinib sensitivity in EGFR-mutant NSCLC cells
2024-7-2
lncRNA-WAL promotes triple-negative breast cancer aggression by inducing β-catenin nuclear translocation
2024-7-1
Small-cell lung cancer neuronal features and their implications for tumor progression, metastasis, and therapy
2024-6-24
Characterization of Wnt Signaling Pathway Aberrations in Metastatic Prostate Cancer
2024-6-24
miR-497 target gene regulatory network in angiosarcoma
2024-6-21
Hepatitis B virus X protein represses expression of tumor suppressor PTPN18 in hepatocellular carcinoma
2024-6-21
Long non-coding RNA MSL3P1 regulates CUL3 mRNA cytoplasmic transport and stability and promotes lung adenocarcinoma metastasis
2024-6-18
MLLT6/ATF2 axis restrains breast cancer progression by driving DDIT3/4 expression
2024-6-14
Crizotinib enhances PARP inhibitor efficacy in ovarian cancer cells and xenograft models by inducing autophagy
2024-6-14
RNA binding protein Lin28B promotes chronic myeloid leukemia blast crisis by transcriptionally upregulating miR-181d
2024-6-7
Intrinsic epigenetic state of primary osteosarcoma drives metastasis
2024-6-6
Ubiquitin ligase TRIM22 inhibits ovarian cancer malignancy via TCF4 degradation
2024-6-6
NSCLC Extracellular Vesicles Containing miR-374a-5p Promote Leptomeningeal Metastasis by Influencing Blood‒Brain Barrier Permeability
2024-6-6
Selected Articles from This Issue
2024-6-4
Clinically relevant humanized mouse models of metastatic prostate cancer facilitate therapeutic evaluation
2024-5-31
Mechanisms of glioblastoma replication: Ca2+ flares and Cl- currents
2024-5-31
MYC Family Amplification Dictates Sensitivity to BET Bromodomain Protein Inhibitor Mivebresib (ABBV075) in Small-Cell Lung Cancer
2024-5-15
Neem Leaf Glycoprotein Disrupts Exhausted CD8+ T-Cell–Mediated Cancer Stem Cell Aggression
2024-5-14
Selected Articles from This Issue
2024-5-2
Pediatric Chordoma: A Tale of Two Genomes
2024-5-1
<i>DROSHA</i> Regulates Mesenchymal Gene Expression in Wilms Tumor
2024-4-22
Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer
2024-4-22
ETS1, a target gene of the EWSR1::FLI1 fusion oncoprotein, regulates the expression of the focal adhesion protein TENSIN3
2024-4-8
Y Chromosome Loss and Implications for Oncology
2024-4-4
Selected Articles from This Issue
2024-4-2
Retraction: Minocycline Targets the NF-κB Nexus through Suppression of TGF-β1-TAK1-IκB Signaling in Ovarian Cancer
2024-4-1
PIGA Mutations and Glycosylphosphatidylinositol Anchor Dysregulation in Polyposis-Associated Duodenal Tumorigenesis
2024-3-28
Hepatitis B Virus–Mediated m6A Demethylation Increases Hepatocellular Carcinoma Stemness and Immune Escape
2024-3-28
Distinct Regulation of ASCL1 by the Cell Cycle and Chemotherapy in Small Cell Lung Cancer
2024-3-21
Vasorin Exocytosed from Glioma Cells Facilitates Angiogenesis via VEGFR2/AKT Signaling Pathway
2024-3-15
FATP5 Is Indispensable for the Growth of Intrahepatic Cholangiocarcinoma
2024-3-13
Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
2024-3-5
lncRNA <i>JPX</i> Promotes Tumor Progression by Interacting with and Destabilizing YTHDF2 in Cutaneous Melanoma
2024-3-5
SCUBE3 Exerts a Tumor-Promoting Effect in Tongue Squamous Cell Carcinoma by Promoting CEBPA Binding to the CCL2 Promoter
2024-3-5
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远